Cited by 79Wnt/β-catenin signaling in development and cancerCancer, Hypoxia, and MetabolismSignaling Pathways in Disease

HIF-2α Enhances β-Catenin/TCF-Driven Transcription by Interacting with β-Catenin

Open access
Choi, Hyunsung, Chun, Yang-Sook, Kim, Tae-You, Park, Jong-Wan·2010·Cancer Research

Abstract

The tumor-promoting factors β-catenin and hypoxia-inducible factor (HIF) are often found to be coactivated in rapidly growing tumors. Recently, it was shown that HIF-1α negatively regulates Wnt/β-catenin signaling by sequestering β-catenin from β-catenin/T-cell factor (TCF). However, no investigation has been undertaken on the involvement of HIF-2α in β-catenin regulation. In this study, it was found that, like HIF-1α, HIF-2α interacts with β-catenin, but at a different site. Furthermore, HIF-2α was found to assemble with β-catenin/TCF and facilitate gene transcription. Mutational analyses revealed that transactivation domains of HIF-2α promote p300 coactivator recruitment by β-catenin. Furthermore, HIF-2α and β-catenin were found to associate in the nuclei of 786-0 renal cell carcinoma cells, and HIF-2α was found to be required for β-catenin activation in these cells and for their proliferation. These results suggest that this interaction contributes to the unrestrained growth of tumor cells containing coactivated HIF-2α and β-catenin. Interestingly, these actions of HIF-2α oppose those of HIF-1α on β-catenin and cell growth, and this suggests that HIF-1α/HIF-2α balance may importantly determine cell growth when hypoxia and Wnt stimulation coexist. Cancer Res; 70(24); 10101–11. ©2010 AACR.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-10-0505

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The HIF-2α bias in ccRCC is attributed to HIF-2α being more potent than HIF-1α at inducing pro-tumorigenic factors such as Cyclin D1, TGF-α, VEGFA, c-Myc, and β-catenin.

    “The HIF-2α bias observed in ccRCC has been attributed to the increased potency of HIF-2α compared to HIF-1α in promoting pro-tumorigenic factors such as Cyclin D1, TGF-α, VEGFA, c-Myc and β-catenin [14,18–20].”

    From Revisiting the HIF switch in the tumor and its immune microenvironment. (2022) · cites this paper as [14]

    The Introduction (p. 1) and Discussion (pp. 9–10) describe HIF-2α as more growth-promoting than HIF-1α in ccRCC and link that difference to c-Myc and β-catenin signaling. The Results (p. 8) also report effects on cyclin D1. The passages do not establish the claimed comparative potency for TGF-α or VEGFA, so the full list of factors is not supported by this paper. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • Beyond canonical HRE-driven transcription, HIF isoforms differentially affect signaling pathways by interacting with non-PAS proteins such as p53, c-MYC, β-catenin, and the Notch intracellular domain.

    “Apart from canonical HRE-mediated transcription, the HIF isoforms differentially modulate signaling pathways through interaction with proteins that do not contain PAS domains, such p53, the c-MYC proto-oncogene, β-catenin and the Notch intracellular domain (Fig. 2A) [11–15].”

    From Revisiting the HIF switch in the tumor and its immune microenvironment. (2022) · cites this paper as [14]

    The Discussion (p. 9) describes HIF-1α interactions with p53, c-Myc, and β-catenin, and reports that HIF-1α and HIF-2α affect β-catenin signaling differently. Our copy does not address an interaction with the Notch intracellular domain or identify these partners as proteins without PAS domains. (LLM, conf=0.87)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 31 · Cited by 79

Research works printed but not linked: 1

  1. [2]2. Wang GL, Semenza GL. Purification and characterization of hypoxiainducible factor 1. J Biol Chem 1995;270:1230 -7.

Authors
Choi, H., Chun, Y.-S., Kim, T.-Y., & Park, J.-W.
Affiliations
Seoul National University (KR)
Corresponding author
Park, Jong-Wan
Venue
Cancer Research
Published
2010-12-14
Volume
70
Issue
24
Pages
10101-10111
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W2154610459
Cited by
79
References
31
Citations by year
2026: 1 · 2025: 2 · 2024: 1 · 2023: 3 · 2022: 3 · 2021: 4 · 2020: 5 · 2019: 4 · 2018: 3 · 2017: 5 · 2016: 9 · 2015: 12 · 2014: 4 · 2013: 7 · 2012: 14
FWCI
2.99
Type
journal article
Language
en
Open access
Locations
  • Cancer Research (publishedVersion)
  • PubMed (publishedVersion)
  • Seoul National University Open Repository (Seoul National University) (submittedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
Keywords
HIF-2α, β-catenin, T-cell factor, Wnt/β-catenin signaling, transcriptional coactivation, p300 coactivator, protein-protein interaction, renal cell carcinoma, tumor cell proliferation, hypoxia, HIF-1α, cell growth
MeSH terms
Transcription Factor 4, Endothelial PAS Domain-Containing Protein 1, Carcinoma, Renal Cell, Humans, Kidney Neoplasms, Transcription Factors, Transcription, Genetic, Signal Transduction, Transcriptional Activation, Cell Hypoxia, Protein Structure, Tertiary, Cell Line, Tumor, Cell Growth Processes, E1A-Associated p300 Protein, beta Catenin, Basic Helix-Loop-Helix Leucine Zipper Transcription Factors, Basic Helix-Loop-Helix Proteins, HEK293 Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review